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Recombinant protein production in prokaryotic and eukaryotic organisms was a key enabling technology for the
rapid development of industrial and molecular biotechnology. However, despite all progress the improvement of
protein production is an ongoing challenge and of high importance for cost-effective enzyme production. With the
epMEGAWHOP mutagenesis protocol for vector backbone optimization we report a novel directed evolution based
approach to increase protein production levels by randomly introducing mutations in the vector backbone. In the
current study we validate the epMEGAWHOP mutagenesis protocol for three different expression systems. The latter
demonstrated the general applicability of the epMEGAWHOP method. Cellulase and lipase production was doubled
in one round of directed evolution by random mutagenesis of pET28a(+) and pET22b(+) vector backbones.
Protease production using the vector pHY300PLK was increased ~4-times with an average of ~1.25 mutations per
kb vector backbone. The epMEGAWHOP does not require any rational understanding of the expression machinery
and can generally be applied to enzymes, expression vectors and related hosts. epMEGAWHOP is therefore from
our point of view a robust, rapid and straight forward alternative for increasing protein production in general and
for biotechnological applications.
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Development of cloning and expression technologies to
produce recombinant proteins in prokaryotic and
eukaryotic organisms enabled the production of numer-
ous enzymes for diagnostic and industrial applications
such as food, leather, textile or detergent industry (Kirk
et al. 2002; Rai and Padh 2001). Recombinant production
of proteins in prokaryotic hosts is commonly increased by
optimization of cultivation or fermentation conditions
(temperature, aeration, media composition and/or the
fermentation type, such as batch, fed-batch or con-
tinuous), codon optimization (Gustafsson et al. 2004;
Li et al. 2003), co-expression of chaperones (Thomas
et al. 1997), increasing the lifetime of mRNA (Terpe
2006), exchanging/modifying promoters and/or signal
peptides (Caspers et al. 2010; Degering et al. 2010;* Correspondence: u.schwaneberg@biotec.rwth-aachen.de
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promoter and gene (Brosius et al. 1985), protein fu-
sion technology (e.g. NusA, maltose-binding protein
[MBP] or glutathione S-transferase [GST]) (Cabrita
et al. 2006), or by metabolic engineering (Heyland
et al. 2011; Kabisch et al. 2012).
Directed evolution has become a standard approach to
tailor enzyme properties such as activity, solubility,
temperature or organic solvent resistance to often non-
natural requirements in industrial production. In di-
rected enzyme evolution campaigns enzyme production
is often unexpectedly increased in initial rounds (Tee
and Schwaneberg 2007). A typical directed evolution ex-
periment comprises three iterative steps of (1) diversity
generation, (2) screening to identify improved variants
out of a large pool of variants, and (3) isolating the genes
encoding for improved variants (Shivange et al. 2009).
The screening system plays a pivotal role for reliably
identifying improved enzyme variants. Among the
screening formats, 96-well microtiter plates are com-
monly used in directed evolution experiments withOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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and Schwaneberg 2007). Recent developments in high
throughput screening technologies comprise through-
puts of 106-108 based on flow cytometry (Ruff et al. 2012;
Tu et al. 2011) and microfluidics (Fallah-Araghi et al.
2012; Kintses et al. 2012). In this work we report a novel
strategy to increase enzyme production in bacterial hosts
(E. coli and B. subtilis), which is based on the ‘megaprimer
PCR of whole plasmid method’ (MEGAWHOP) (Miyazaki
2003; Miyazaki 2011). In our modified error-prone
MEGAWHOP method (epMEGAWHOP) mutated vector
backbone libraries were generated by amplification under
error-prone PCR conditions using non-mutated genes as
megaprimers, and subsequently screened for increased ac-
tivity. The general applicability of the developed strategy
was proven by using three enzymes (CelA2, BSLA and
subtilisin Carlsberg) in three different vector-systems
(pET28a(+), pET22b(+) and pHY300PLK) and two differ-
ent and industrially important expression hosts (E. coli
(Baneyx 1999; Jana and Deb 2005) and B. subtilis (Terpe
2006; Westers et al. 2004)). In all three cases an increased
enzyme production was obtained with optimized vector
backbones.
Materials and methods
All chemicals were of analytical-reagent grade or
higher quality and were purchased from Carl Roth
GmbH (Karlsruhe, Germany), Sigma-Aldrich (Hamburg,
Germany) and AppliChem (Darmstadt, Germany). En-
zymes were purchased from New England Biolabs (Beverly,
USA) and Fermentas (St. Leon-Rot, Germany). Oligonucle-
otides were purchased from Eurofins MWG Operon
(Ebersberg, Germany) in salt-free form. Plasmid extraction
and PCR purification kits were purchased from Macherey-
Nagel (Düren, Germany). Microtiter plates (Greiner
Bio-One GmbH, Frickenhausen, Germany) were incu-
bated in a Multitron II Infors shaker (Infors AG,
Bottmingen, Switzerland). DNA concentrations were quan-
tified using a NanoDrop photometer (ND-1000, NanoDrop
Technologies, Wilmington, USA). A Mastercycler gra-
dient (Eppendorf, Hamburg, Germany) and thin-wall
PCR tubes (Multi ultra-tubes; 0.2 mL; Carl Roth, Germany)
were used in all PCRs.
Strains and plasmids
E. coli DH5α, E. coli BL21-Gold (DE3) (purchased from
Agilent Technologies; Santa Clara, USA) and B. subtilis
DB104 (Kawamura and Doi 1984) were used in this
study as hosts for DNA manipulation and recombinant
protein production. For construction of the expression
vectors for the E. coli strains (DH5α; BL21-Gold (DE3)),
and the plasmids pET28a(+) or pET22b(+) (Novagen;
Darmstadt, Germany) were used. In case of B. subtilis
DB104 the shuttle vector pHY300PLK (Takara Bio Inc.,Shiga, Japan) was employed. Chemically competent E.
coli DH5α and E. coli BL21-Gold (DE3) cells with deter-
mined transformation efficiencies of 3 × 107 and 3 × 106
cfu/μg pUC19, respectively, were prepared in-house
using the rubidium chloride method (Hanahan 1983).
Transformation of B. subtilis DB104 was performed
using a recently developed method which is based on
natural competence (Vojcic et al. 2012).
Gene cloning, construction of expression vectors,
and sequencing
CelA2
The parent celA2 (GenBank: JF826524.1; (Lehmann et al.
2012)) was ordered as a synthetic gene from GeneArt
(Regensburg, Germany) with an optimized codon usage
for E. coli (GenBank submission number ID1624106)
flanked by an NcoI and an EcoRI restriction site. Addition-
ally, celA2 contains an N-terminal His-tag, followed by a
TEV-protease sequence. After double digestion with NcoI
and EcoRI, the fragment was subcloned into pET28a(+).
The generated construct, named pET28a(+)-CelA2, was
transformed into E. coli DH5α and sequenced to exclude
mutations.
Bacillus subtilis lipase A (BSLA)
After double digestion of the parent Bacillus subtilis lip-
ase A (BSLA) (GenBank: JX048066.1) with NdeI and
XhoI, the fragment was subcloned using T4 DNA ligase
into pET22b(+). The resultant recombinant plasmid,
named pET22b(+)-BSLA, contains a C-terminal His-tag
and a pelB leader sequence. The plasmid construct was
transformed into E. coli DH5α and sequenced to exclude
mutations.
Subtilisin Carlsberg
After double digestion of a subtilisin Carlsberg variant
(GenBank: HM147766.1, harboring the silent mutations
C479G, T480C, G482A, G869A, T1052C and G1055C)
with BamHI and XmaI, the gene was subcloned into
pHY300PLK using T4 DNA ligase. The resulting recom-
binant plasmid, named pHYscarlsberg was transformed
into E. coli DH5α and sequenced to exclude mutations.
DNA sequencing of all three recombinant plasmids
was conducted at Eurofins MWG Operon (Ebersberg,
Germany) and Clone Manager 9 Professional Edition
(Sci-Ed software, Cary, USA) was used for all sequence
alignments.
Generation of error-prone MEGAWHOP libraries
Megaprimers for each target gene were generated by
PCR under standard conditions. The amplification of
celA2 and BSLA was performed using unmodified DNA
primers 5’-GTTATTGCTCAGCGGTGGCAGCAGC-3’
and 5’-TAATACGACTCACTATAGGGGAATTGTGAG
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minator region. The amplification of the subtilisin
Carlsberg gene includes promoter, pre- and pro-sequence
and was performed using unmodified DNA primers 5’-
CAGATTTCGTGATGCTTGTCAGG-3’ and 5’-CGTT
AAGGGATCAACTTTGGGAG-3’ (5 μM each). For the
PCR (98°C for 30 sec, one cycle; 98°C, 15 sec/63°C,
15 sec/68°C, 2 min (celA2) or 30 sec (BSLA, subtilisin
Carlsberg), 25 cycles; 68°C for 10 min, one cycle), PfuS
DNA polymerase (2.5 U), dNTP mix (10 mM), template
(pET28a(+)-CelA2, pET22b(+)-BSLA and pHYscarlsberg:
30 ng/μL) were used. The PCR products (megaprimers)
were purified using a PCR purification kit.
For the epMEGAWHOP PCR (72°C for 5 min, one
cycle; 94°C for 90 sec, one cycle; 94°C, 45 sec/60°C,
45 sec/72°C, 5 min, 25 cycles; 72°C for 10 min, one cycle),
Taq DNA polymerase (2.5 U), dNTP mix (10 mM)
together with plasmid template (pET28a(+)-CelA2,
pET22b(+)-BSLA or pHYscarlsberg: 120 ng), megaprimer
(pET28a(+)-CelA2, pET22b(+)-BSLA or pHYscarlsberg:
550 ng) and 0.05 mM Mn2+ were used. Following the
epMEGAWHOP PCR, DpnI digestion (20 U) of the
template was performed overnight at 37°C. The
epMEGAWHOP PCR product was transformed into
E. coli DH5α. All colonies from the agar plates were
used for plasmid isolation and subsequently transformed
into their expression host. The plasmids pET28a(+)-CelA2
and pET22b(+)-BSLA were transformed in E. coli
BL21-Gold (DE3) and pHYscarlsberg was transformed
in B. subtilis DB104.
Indicator plates for pre-screening
In all three screening systems a halo formation can be
used to semi-quantify enzymatic activity as indicator for
enzyme production.
Detection of cellulolytic activity
Azo-CarboxyMethyl-Cellulose (Azo-CM-Cellulose, Megazyme,
Bray, Ireland) was used as substrate for determining cellu-
lolytic activity (Hughes et al. 2006). LB agar plates
supplemented with 0.125% (w/v) Azo-CM-Cellulose,
50 μg/mL kanamycin and 0.1 mM isopropyl-thio-β-D-
galactoside (IPTG) were used as indicator plates for pre-
screening.
Detection of lipolytic activity
Tributyrin was used as substrate for lipolytic activity detec-
tion (Alquati et al. 2002). LB agar plates supplemented with
100 μg/mL ampicillin, 1.5% (v/v) tributyrin, 0.15% (w/v)
gum arabic were used as indicator plates for pre-screening.
Detection of proteolytic activity
Skim milk was used as substrate for proteolytic activity
detection (Sokol et al. 1979). LB agar plates supplementedwith 1% (w/v) skim milk and 15 μg/mL tetracycline were
used as indicator plates for pre-screening.
Expression in microtiter plates
Growth conditions and expression of CelA2 in 96-well
microtiter plates
Colonies displaying cellulolytic activity in the indicator
agar plates were transferred into 96-well microtiter
plates (flat-bottomed, polystyrene plates). Cultivation and
enzyme expression in microtiter plates was performed as
previously described (Lehmann et al. 2012) and superna-
tants of lysates were subsequently used for kinetic
characterization.
Growth conditions and expression of BSLA in 96-well
microtiter plates
Colonies displaying lipolytic activity in the indicator agar
plates were transferred into 96-well microtiter plates
(flat-bottomed, polystyrene plates) containing 200 μL LB
medium supplemented with 50 μg/mL ampicillin and in-
cubated (pre-culture; 37°C, 900 rpm, 24 h, 70% humidity).
An expression plate contained 150 μL auto-induction
medium (1.2% (w/v) casein hydrolysate, 2.4% (w/v) yeast
extract, 0.5% (w/v) glycerol, 0.05% (w/v) glucose, 0.02%
(w/v) lactose and potassium phosphate buffer (90 mM;
pH 7.0) was inoculated with the pre-culture (10 μL) and
incubated (main culture; 37°C, 900 rpm, 16 h, 70% hu-
midity). After expression, the microtiter plates were
centrifuged (4000 g, 20 min, 4°C) to separate the cells
from the culture supernatant. Using the expression vector
pET22b(+) including pelB sequence, the activity of BSLA
can be detected in the culture supernatant (Funke et al.
2003; Khushoo et al. 2004; Yedavalli and Rao 2013).
Culture supernatant, including the BSLA was transferred
after centrifugation into a 96-well microtiter plate for fur-
ther analysis.
Growth conditions and expression of subtilisin Carlsberg
in 96-well microtiter plates
Single colonies of B. subtilis DB104 which show proteo-
lytic activity on LB skim milk agar plates were trans-
ferred into flat-bottom microtiter plates (pre-culture
plates) containing buffered LB medium (200 μL; 1%
(w/v) tryptone, 0.5% (w/v) yeast extract and 1% (w/v)
sodium chloride, 17 mM potassium dihydrogen phos-
phate, 72 mM dipotassium hydrogen phosphate, 15 μg/
mL tetracycline) and incubated (37°C, 900 rpm, 18 h,
70% humidity). The volume of 10 μL pre-culture was
used to inoculate the main culture (150 μL buffered LB,
37°C, 900 rpm, 24 h, 70% humidity). After expression,
the microtiter plates were centrifuged (4000 g, 20 min,
4°C) to separate cells from secreted protease. The super-
natant was transferred into a microtiter plate for further
analysis.
Figure 1 The five epMEGAWHOP steps to increase protein
production by vector backbone mutagenesis. Step I:
megaprimer generation, Step II: amplification of the vector
backbone under error-prone conditions (0.05 mM Mn2+), Step III:
transformation into E. coli DH5α and isolation of plasmids. The
expression hosts (E. coli BL21-Gold (DE3) or B. subtilis DB104) were
transformed subsequently with the isolated plasmids, Step IV: agar
plate pre-screening with selection based on halo formation, and
Step V: screening in microtiter plate format to quantify increase in
enzyme production.
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Performance of the lacI repressor system used in the
above described growth and assay conditions was ana-
lyzed for each pET expression system. CelA2 and BSLA
production was performed in TBkan- or LBamp-medium
without supplementing IPTG or the induction compo-
nents glucose and lactose.
Screening systems
Fluorometric assay for determining cellulolytic activity of
CelA2
Cellulolytic activity was measured using 4-Methylumbelliferyl
-ß-D-cellobioside (4-MUC) as a fluorogenic substrate
(Boschker and Cappenberg 1994; Chernoglazov et al.
1989). The cultivation and enzyme reaction was performed
as recently reported (Lehmann et al. 2012).
Colorimetric assay for determining lipolytic activity of
BSLA
The lipolytic activity of BSLA in the supernatant was
determined using p-nitrophenyl butyrate (pNPB) (Shirai
et al. 1982). The final reaction contained 0.5 mM p-
nitrophenyl butyrate dissolved in 10 μL acetonitril,
180 μL triethanolamin buffer (50 mM; pH 7.4) and
10 μL of five times diluted supernatant. The release of
p-nitrophenolate was continuously monitored at 410 nm
in a microtiter plate reader (Tecan Infinite M1000 Pro)
for quantifying the BSLA production.
Colorimetric assay for determining proteolytic activity of
subtilisin Carlsberg
Proteolytic activity was determined in a microtiter plate
using the synthetic peptide substrate succinyl-L-Ala-L-
Ala-L-Pro-L-Phe-p-nitroanilide (suc-AAPF-pNA) (DelMar
et al. 1979). Proteolytic reaction of subtilisin Carlsberg was
started by supplementing 10 μL of the 1:20 diluted super-
natant to Tris/HCl (100 μL; 100 mM, pH 7.5) containing
1 mM suc-AAPF-pNA. The release of p-nitroaniline was
continuously monitored at 410 nm in a microtiter plate
reader (Tecan Infinite M1000 Pro) and the determined ac-
tivity was used for protease quantification.
Sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE)
The SDS-PAGE for CelA2 was performed using a stack-
ing gel (5% (w/v) acrylamide) and a separating gel (15%
(w/v) acrylamide) (Laemmli 1970). Proteins in the super-
natant (including BSLA or subtilisin Carlsberg) were
precipitated with trichloroacetic acid (TCA; 30% (v/v);
15 min on ice), resuspended after washing with acetone
in Tris/HCl (100 mM; pH 8.0). The proteins in the
supernatant after centrifugation of cell lysate (CelA2) as
well as the precipitated and resuspended proteins from
the cell culture supernatant (BSLA and subtilisinCarlsberg) were loaded and separated by SDS-PAGE.
Subsequently, the SDS-PAGE gel was stained with
Coomassie brilliant blue.
Results
In the first sections the development of the epMEGAWHOP
protocol is described and the screening for increased
activity of the selected cellulase, lipase and protease. Sub-
sequently, the obtained variants showing increased activity
were analyzed in detail to validate the epMEGAWHOP
method.
Library generation screening
Figure 1 shows the scheme of the developed epMEGAWHOP
protocol starting from the generation of megaprimers by
PCR (Step I). Followed by an amplification of the whole
plasmid under error-prone conditions (0.05 mM Mn2+)
(Step II) and digestion of the methylated template. In
(Step III) the resulting circular DNA is transformed into
E. coli DH5α cells. The plasmids are subsequently isolated
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host (E. coli BL21-Gold (DE3) or B. subtilis DB104) and
grown on indicator plates (Step IV). Colonies showing
halos are transferred into microtiter plates for quantifica-
tion of enzymatic activity (Step V). Table 1 summarizes
the expression constructs used for epMEGAWHOP
development.
Approximately 1000 CFU were pre-screened using the
corresponding agar plate detection systems for all three
expression systems. Ninety promising variants were se-
lected based on halo formation and rescreened more
precisely in 96-well microtiter plate format. The most
promising candidates (one cellulase, one lipase and one
protease) were analyzed in detail to confirm that the in-
creased production can be attributed to an optimized
vector backbone. For the latter the wild-type genes
(CelA2, BSLA and subtilisin Carlsberg) were cloned into
the mutated backbone as described under Materials and
Methods with subsequent rescreening in three 96-well
microtiter plate measurements in which each construct
was expressed 8 times per plate.
Activity and expression analysis
The activity of the three identified variants compared to
their parents is shown in Figure 2a. Mutagenized vector
backbones of pET28a(+)M1-CelA2 and pET22b(+)M1-
BSLA showed compared to the respective ‘wild-type’ a
2-fold increased lipolytic and cellulolytic activity. These
activity increases can be correlated to the amount of
expressed enzyme which is visualized within a SDS-
PAGE in Figure 2b. The mutated vector backbone of
pHYM1-scarlsberg showed the highest increase in
secreted subtilisin Carlsberg production (4-fold in-
creased proteolytic activity). The increased proteo-
lytic activity correlates well with the increase in the
protease content (see SDS-PAGE analysis Figure 2a,
b; the whole SDS-PAGE picture is available in the
Additional file 1: Figure S1).
Analysis of the lacI repressor system
Expression under inducing and non-inducing conditions
was performed to analyze whether the lacI repressor con-
tributes to increased production levels. The constructs
pET28a(+)-CelA2 and pET22b(+)-BSLA are under the
control of lacI repressor. Figure 3 shows under non-
induced conditions a significant difference in activity/
lipase production in the pET22b(+)-BSLA expressionTable 1 Overview of the expression systems used for develop
Expression host Plasmid Enzym
E. coli BL21-Gold (DE3) pET28a(+) Cellula
E. coli BL21-Gold (DE3) pET22b(+) Lipase
B. subtilis DB104 pHY300PLK Proteasvector: the mutated backbone yielded 0.34 U/mL
compared to 0.04 U/mL of the ‘parent’ pET22b(+).
The latter result proves that lacI influences lipase
production in pET22b(+)M1-BSLA. Sequencing re-
sults confirmed two mutations in lacI (see Table 2).
An opposite results was found for the pET28a
(+)-CelA2 and the pET28a(+)M1-CelA2 expression
systems in which under non-induced conditions only
very low cellulase activities could be determined
(<0.02 U/mL). These results prove that the lacI is an
effective repressor even in the optimized vector back-
bone. Sequencing results confirmed that there are no
mutations in the lacI within the pET28a(+)M1-CelA2
expression system (Table 2). In all four constructs the
lacI repressor is functional as confirmed by IPTG in-
duction (Figure 3).
Sequence analysis
Sequence analysis was performed by sequencing the vec-
tor backbones and inserts. An average mutation fre-
quency of 1.00-1.25 mutations per 1 kb plasmid DNA
was obtained (Additional file 1: Figure S2) and all inserts
did not contain a mutation. Table 2 summarizes posi-
tions of mutations in the vector backbones and assigns
mutations to functional regions. Interestingly, the anti-
biotic resistance is mutated in all three vector systems,
and functional regions such as the origin of replication
(in pET28a(+)M1-CelA2; pHYM1-scarlsberg), promoter
(pET28a(+)M1-CelA2), repressor (pET22b(+)M1-BSLA),
and terminator (pHYM1-scarlsberg).
Discussion
The MEGAWHOP method is commonly used for clon-
ing random mutagenesis libraries via whole plasmid
PCR into the desired expression vector containing the
parent gene (Miyazaki 2011). In general enzyme proper-
ties such as activity, substrate specificity or stability are
improved in directed evolution experiments employing
MEGAWHOP (Agudo et al. 2012; Martinez et al. 2013;
Sass et al. 2012). The developed epMEGAWHOP does
not aim to improve enzymes properties. epMEGAWHOP
aims to increase the enzyme production without altering
its properties through vector backbone mutagenesis. The
error-prone (ep-) label was placed in front of the
MEGAWHOP term to point out the main difference that
the vector amplification is performed under error-prone
conditions.ing and validating the epMEGAWHOP method
e Location of expressed enzyme
se (CelA2) Intracellular
A (BSLA) Periplasmatic
e (subtilisin Carlsberg) Extracellular
Figure 2 Activity studies and SDS-PAGE visualization of produced CelA2, BSLA, subtilisin Carlsberg wild type. a) Activity measurements
are performed with not optimized (left column) and mutagenized vector backbones (right column) in 96-well microtiter plate. Constructs with an
M1 label habor an epMEGAWHOP optimized vector backbone; b) Visualization of production levels of CelA2 (proteins in supernatant of lysate),
BSLA and subtilisin Carlsberg (proteins in culture supernatant after precipitation) by SDS-PAGE in combination with Coomassie brilliant blue
staining. The reported relative activity values are the average of three 96-well microtiter plate measurements in which each construct was
expressed 8 times per plate. Deviations are calculated from the corresponding mean values.
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enzyme production by optimizing a vector backbone
through mutagenesis and high-throughput screening. The
epMEGAWHOP method (Figure 1) was validated by
employing three different vector constructs with three
different enzymes (cellulase: pET28a(+)-CelA2; lipase:
pET22b(+)-BSLA; protease: pHY-scarlsberg). A single
round of vector backbone mutagenesis and screening
yielded significantly increased production levels for all
three enzymes (~2-fold for CelA2, ~2-fold for BSLA
and ~4-fold for subtilisin Carlsberg). Control experimentsFigure 3 Functional study of the lacI repressor under induced (left ba
(+)-CelA2, pET28a(+)M1-CelA2, pET22b(+)-BSLA and pET22b(+)M1-BSL
epMEGAWHOP optimized vector backbone. Enzyme activity levels were de
microtiter plate formats for CelA2 and BLSA. The reported values are the av
hydrolase was expressed 8 times per plate and deviations are calculated frothrough subcloning and sequencing confirmed that only
the vector backbones were mutated with an average muta-
tion frequency of ~1.25 mutations per kb. The increase in
cellulase, lipase and protease production demonstrate
from our point of view that epMEGAWHOP is likely a
general method for increasing enzyme production. This is
supported by the selection of common expression systems
which cover cytosolic (cellulase), periplasmatic (lipase),
and extracellular production (protease) in combination
with two industrially attractive bacterial hosts (E. coli
and B. subtilis). The main goal of this report is to validaters) and non-induced (right bars) conditions employing pET28a
A expression systems. Constructs with an M1 label harbor an
termined with the corresponding screening systems in 96-well
erage of three 96-well microtiter plate measurements in which each
m the corresponding mean values.
Table 2 Sequencing results of vector backbones that were subjected to epMEGAWHOP optimization
pET28a(+)-CelA2 pET22b(+)-BSLA pHY-scarlsberg
bp Substitution Region bp Substitution Region bp Substitution Region
wt - M1 wt - M1 wt - M1
488 A - T f1 origin 123 T - C T7 term 209 A - G Tet
850 G - C Kan 2007 A - G na 684 A - G Tet
2233 T - C pBR322 ori 3701 A - G Tet 1584 T - C pTet
2396 T - C na 4563 T - C lacI 3238 T - C pAMP
3170 T - C na 4794 C - T lacI 4221 T - C na
5193 A - T T7 prom 4332 A - - ori-177
The positions of the mutations in the corresponding vector backbones are based on the sequenced vector backbone prior epMEGAWHOP. Alignments of all three
vector systems to the corresponding ‘parents’ are included in Additional file 1: Figure S1. Nucleotide position 1 is the base after the stop codon (ATT, TAA) of the
inserted genes.
na: no corresponding function of the gene sequence could be assigned.
Kan/Tet: Kanamycin/Tetracyclin resistance gene.
pTET/pAMP: promoter region Tetracyclin/Ampicilin resistance gene (identified with a promoter prediction tool (Reese 2001)).
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optimization and not to elucidate in depth the interplay in
the complex protein production machinery from the ex-
pression to the produced enzyme. The effect of randomly
introduced mutations in the vector backbone has to our
best knowledge not been investigated in a systematic
manner.
Table 2 shows that functional regions such as anti-
biotic resistance, promoter, repressor or origin of repli-
cation were mutated. The mutations can be classified
into three groups according to the region in the expres-
sion vector: 1) in the kanamycin/tetracycline resistance
cassette; 2) once in the promoter and terminator region
and 3) twice in the origin of replication. It is known that
through the introduction of an expression vector into
E. coli or other hosts for recombinant protein produc-
tion, the native cell functions at many levels can be
perturbed (e.g. ribosome functions, RNA turnover as well
as energy and intermediary metabolism of the cell) (Bailey
1993; Hoffmann et al. 2002; Lin-Chao et al. 2006). This
effect is very difficult, however, to predict or attribute to a
specific change in the host metabolism, due to the com-
plexity of the system. For example, a reduced but suffi-
cient expression of the resistant marker could allow
spending more metabolic resources into expressing the
recombinant enzyme. On the other hand, a higher resist-
ance marker expression could allow a higher specific
growth rate of the cells which directly correlates with the
rate of recombinant protein synthesis (Hoffmann and
Rinas 2004).
Elucidating the influence of each mutation and each
region on the cellulase, lipase, and protease production
would include the introduction of the individual muta-
tions in the parental vector backbones to gain a deeper
understanding on the complex machinery from expres-
sion system to produced enzyme.A main prerequisite for a successful epMEGAWHOP
experiments is a reliable high-throughput screening
system which allows an identification of improved
expression variants. It is likely that the mutational load
has to be optimized depending on the vector size; an
average mutation frequency of 1.25 mutations per 1 kb
prove to be efficient to increase enzyme production and
all three sequenced vector backbones contained five to
six mutations.
In essence, we developed a novel method to increase
recombinant protein production based on the random
mutagenesis of vector backbones (epMEGAWHOP).
The general applicability of epMEGAWHOP was vali-
dated by increasing the protein production after one
round of directed evolution for E. coli BL21-Gold (DE3)/
pET28a(+)-CelA2, E. coli BL21-Gold (DE3)/pET22b
(+)-BSLA and B. subtilis DB104/pHY-scarlsberg. The
main advantage of epMEGAWHOP is that it doesn’t
require a rational understanding of the expression ma-
chinery and can generally be applied to enzymes, expres-
sion vectors and related hosts. Changing expression
vector or promoter systems to achieve higher enzyme
yields often requires re-optimization of media compos-
ition, induction times and cell densities, together with ex-
pression and harvest time, in contrast to epMEGAWHOP.
Overall, epMEGAWHOP is a robust, rapid and straight
forward alternative and can be used for increasing recom-
binant protein production.Additional file
Additional file 1: Figure S1. SDS-PAGE of produced cellulase (CelA2),
lipase (BSLA) and protease (subtilisin Carlsberg). EV: empty vector control;
WT: non-optimized vector constructs; M1: epMEGAWHOP optimized
vector constructs. Red arrows indicate the bands of target proteins.
Figure S2: Sequencing results: Alignments of all three vector systems
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